BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34524402)

  • 1. Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology.
    Wu Q; Cortez L; Kamali-Jamil R; Sim V; Wille H; Kar S
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34524402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes.
    Yang H; Wang Y; Kar S
    Glia; 2017 Nov; 65(11):1728-1743. PubMed ID: 28722194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells.
    Chung J; Phukan G; Vergote D; Mohamed A; Maulik M; Stahn M; Andrew RJ; Thinakaran G; Posse de Chaves E; Kar S
    Mol Cell Biol; 2018 Jun; 38(11):. PubMed ID: 29530923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.
    Abdullah M; Takase H; Nunome M; Enomoto H; Ito J; Gong JS; Michikawa M
    J Alzheimers Dis; 2016 Jul; 53(4):1433-41. PubMed ID: 27392863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
    Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
    Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
    Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for astrocyte-derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy.
    Kodam A; Ourdev D; Maulik M; Hariharakrishnan J; Banerjee M; Wang Y; Kar S
    Brain Pathol; 2019 Jan; 29(1):28-44. PubMed ID: 29665128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.
    Hui L; Chen X; Geiger JD
    Life Sci; 2012 Dec; 91(23-24):1159-68. PubMed ID: 22580286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol.
    Wang H; Kulas JA; Wang C; Holtzman DM; Ferris HA; Hansen SB
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
    Zhao J; O'Connor T; Vassar R
    J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholesterol transport inhibitor U18666a regulates amyloid precursor protein metabolism and trafficking in N2aAPP "Swedish" cells.
    Davis W
    Curr Alzheimer Res; 2008 Oct; 5(5):448-56. PubMed ID: 18855586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
    Lee M; Ban JJ; Yang S; Im W; Kim M
    Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Aβ₁₋₄₂ Oligomers on APP Processing and Aβ₁₋₄₀ Generation in Cultured U-373 Astrocytes.
    Ourdev D; Foroutanpay BV; Wang Y; Kar S
    Neurodegener Dis; 2015; 15(6):361-8. PubMed ID: 26606591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential function for neuronal exosomes: sequestering intracerebral amyloid-β peptide.
    Yuyama K; Sun H; Usuki S; Sakai S; Hanamatsu H; Mioka T; Kimura N; Okada M; Tahara H; Furukawa J; Fujitani N; Shinohara Y; Igarashi Y
    FEBS Lett; 2015 Jan; 589(1):84-8. PubMed ID: 25436414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.
    Goetzl EJ; Mustapic M; Kapogiannis D; Eitan E; Lobach IV; Goetzl L; Schwartz JB; Miller BL
    FASEB J; 2016 Nov; 30(11):3853-3859. PubMed ID: 27511944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease.
    Lefort R; Pozueta J; Shelanski M
    J Neurosci; 2012 Aug; 32(31):10674-85. PubMed ID: 22855816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.
    White AR; Maher F; Brazier MW; Jobling MF; Thyer J; Stewart LR; Thompson A; Gibson R; Masters CL; Multhaup G; Beyreuther K; Barrow CJ; Collins SJ; Cappai R
    Brain Res; 2003 Mar; 966(2):231-44. PubMed ID: 12618346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
    Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
    Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.